Mounting evidence suggests that APOA1 plays multifaceted roles in anti-inflammation, anti-insulin resistance, anti-atherosclerosis, and the inhibition of oxidative stress and nitric oxide production, surpassing the effects of HDL-c itself (17, 18). Here, APOA1 is linked to Insulin resistance.